Successful treatment of idiopathic angioedema with ecallantide

被引：8
|
作者：
Berry, Alalia [1 ]
Firszt, Rafael [2 ]
机构：
[1] Univ Utah, Dept Med, Div Allergy & Immunol, Salt Lake City, UT 84158 USA
[2] Univ Utah, Dept Pediat, Div Allergy & Immunol, Salt Lake City, UT 84158 USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2013年 / 1卷 / 03期
关键词：
D O I：
10.1016/j.jaip.2013.03.007
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：297 / 298
页数：2
相关论文
共 50 条
  • [31] FDA Approves Ecallantide (Kalbitor) for Hereditary Angioedema
    不详
    JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (05) : 573 - 573
  • [32] Omalizumab for treatment of idiopathic angioedema
    Goswamy, Vinay P.
    Lee, Kristine E.
    McKernan, Elizabeth M.
    Fichtinger, Paul S.
    Mathur, Sameer K.
    Viswanathan, Ravi K.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 (05) : 605 - +
  • [33] DAPSONE IN THE TREATMENT OF IDIOPATHIC ANGIOEDEMA
    Zhu, N.
    Stafford, W.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S51 - S51
  • [34] Assessment of rebound and relapse following ecallantide treatment for acute attacks of hereditary angioedema
    Bernstein, J. A.
    Shea, E. P.
    Koester, J.
    Iarrobino, R.
    Pullman, W. E.
    ALLERGY, 2012, 67 (09) : 1173 - 1180
  • [35] Ecallantide for treatment of acute hereditary angioedema attacks: Analysis of efficacy by patient characteristics
    MacGinnitie, Andrew J.
    Campion, Marilyn
    Stolz, Leslie E.
    Pullman, William E.
    ALLERGY AND ASTHMA PROCEEDINGS, 2012, 33 (02) : 178 - 185
  • [36] Predictive factors for ecallantide second dose requirement in treatment for acute attacks of hereditary angioedema
    Craig, T.
    Soteres, D.
    Riedl, M.
    Lumry, W.
    MacGinnitie, A.
    Bernstein, J.
    Li, H.
    Campion, M.
    Pullman, W.
    ALLERGY, 2012, 67 : 198 - 198
  • [37] Management of acute attacks of hereditary angioedema: role of ecallantide
    Duffey, Hannah
    Firszt, Rafael
    JOURNAL OF BLOOD MEDICINE, 2015, 6 : 115 - 123
  • [38] Current treatment options for idiopathic angioedema
    Shroba, Jodi
    Hanson, Jill
    Portnoy, Jay
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) : 429 - 433
  • [39] SUCCESSFUL USE OF ECALLANTIDE TO TREAT A HEREDITARY ANGIOEDEMA ATTACK AFTER FAILURE OF C1 INHIBITOR PROPHYLAXIS
    Burke, Shayna
    Petrov, Andrei
    Johnson, Jonas
    MacGinnitie, Andrew
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (02) : 181 - 182
  • [40] ACUTE ATTACKS OF ACQUIRED ANGIOEDEMA RESPONDING TO KALLIKREIN INHIBITOR (ECALLANTIDE)
    Vernon, N.
    Ghaffari, G.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 109 (05) : A90 - A90
12345